Search Results - "Rocchi, Serena"

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project by D'Agostino, Mattia, Cairns, David A, Lahuerta, Juan José, Wester, Ruth, Bertsch, Uta, Waage, Anders, Zamagni, Elena, Mateos, María-Victoria, Dall'Olio, Daniele, van de Donk, Niels W C J, Jackson, Graham, Rocchi, Serena, Salwender, Hans, Bladé Creixenti, Joan, van der Holt, Bronno, Castellani, Gastone, Bonello, Francesca, Capra, Andrea, Mai, Elias K, Dürig, Jan, Gay, Francesca, Zweegman, Sonja, Cavo, Michele, Kaiser, Martin F, Goldschmidt, Hartmut, Hernández Rivas, Jesús María, Larocca, Alessandra, Cook, Gordon, San-Miguel, Jesús F, Boccadoro, Mario, Sonneveld, Pieter

“…Patients with newly diagnosed multiple myeloma (NDMM) show heterogeneous outcomes, and approximately 60% of them are at intermediate-risk according to the…”
Get full text

PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma by Zamagni, Elena, Nanni, Cristina, Mancuso, Katia, Tacchetti, Paola, Pezzi, Annalisa, Pantani, Lucia, Zannetti, Beatrice, Rambaldi, Ilaria, Brioli, Annamaria, Rocchi, Serena, Terragna, Carolina, Martello, Marina, Marzocchi, Giulia, Borsi, Enrica, Rizzello, Ilaria, Fanti, Stefano, Cavo, Michele

“…To evaluate the role of 18F-FDG PET/CT in 282 symptomatic multiple myeloma patients treated up-front between 2002 and 2012. All patients were studied by PET/CT…”
Get full text

Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma by Rocchi, Serena, Tacchetti, Paola, Pantani, Lucia, Mancuso, Katia, Zannetti, Beatrice, Cavo, Michele, Zamagni, Elena

Get full text

Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy by Rocchi, Serena, Zannetti, Beatrice Anna, Marconi, Giovanni, Lanza, Francesco

“…Upfront high-dose therapy with melphalan (HDM) followed by autologous stem cell transplantation (ASCT) has established itself as a core treatment for newly…”
Get full text

Novel insights and therapeutic approaches in secondary AML by Marconi, Giovanni, Rondoni, Michela, Zannetti, Beatrice Anna, Zacheo, Irene, Nappi, Davide, Mattei, Agnese, Rocchi, Serena, Lanza, Francesco

“…Secondary acute myeloid leukemia (sAML) presents as a complex and multifaceted ensemble of disorders, positioning itself as both a challenge and an intriguing…”
Get full text

What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? by Autore, Francesco, Bramanti, Stefania, Lessi, Federica, Innocenti, Idanna, Galli, Eugenio, Rocchi, Serena, Ribolla, Rossella, Derudas, Daniele, Oliva, Stefania, Stefanoni, Paola, Marcatti, Magda, Schenone, Angelo, La Nasa, Giorgio, Crippa, Claudia, Zamagni, Elena, Riva, Marcello, Mazza, Rita, Mannina, Daniele, Sica, Simona, Bacigalupo, Andrea, Laurenti, Luca

“…Autologous peripheral blood stem cell transplantation (aPBSCT) provides optimal outcomes in POEMS syndrome but the definition of the best treatment before…”
Get full text

Monoclonal gammopathy of renal significance (MGRS): Real‐world data on outcomes and prognostic factors by Gozzetti, Alessandro, Guarnieri, Andrea, Zamagni, Elena, Zakharova, Elena, Coriu, Daniel, Bittrich, Max, Pika, Tomáš, Tovar, Natalia, Schutz, Natalia, Ciofini, Sara, Peña, Camila, Rocchi, Serena, Rassner, Michael, Avivi, Irit, Waszczuk‐Gajda, Anna, Chhabra, Saurabh, Usnarska‐Zubkiewicz, Lidia, González‐Calle, Verónica, Mateos, Maria‐Victoria, Bocchia, Monica, Bigi, Flavia, Füllgraf, Hannah, Bhasin‐Chhabra, Bhavna, Gentile, Massimo, Davila, Julio, Vesole, David H., Cavo, Michele, Thapa, Bicky, Crusoe, Edvan, Einsele, Hermann, Legiec, Wojciech, Charliński, Grzegorz, Jurczyszyn, Artur

“…Monoclonal gammopathy of renal significance (MGRS) is a recognized clinical entity. Literature regarding treatment and its outcomes in MGRS is sparse due to…”
Get full text

Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients by Martello, Marina, Solli, Vincenza, Termini, Rosalinda, Kanapari, Ajsi, Remondini, Daniel, Borsi, Enrica, Poletti, Andrea, Armuzzi, Silvia, Taurisano, Barbara, Vigliotta, Ilaria, Mazzocchetti, Gaia, Zamagni, Elena, Merlotti, Alessandra, Tacchetti, Paola, Pantani, Lucia, Rocchi, Serena, Rizzello, Ilaria, Mancuso, Katia, Cavo, Michele, Terragna, Carolina

“…DNA microarrays and RNA-based sequencing approaches are considered important discovery tools in clinical medicine. However, cross-platform reproducibility…”
Get full text

Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma by Bonello, Francesca, Rocchi, Serena, Barilà, Gregorio, Sandrone, Michela, Talarico, Marco, Zamagni, Elena, Scaldaferri, Matilde, Vedovato, Susanna, Bertiond, Cecilia, Pavan, Laura, Bringhen, Sara, Cattel, Francesco, Zambello, Renato, Cavo, Michele, Mina, Roberto

“…The anti-CD38 monoclonal antibody daratumumab is the backbone of most anti-multiple myeloma (MM) regimens. To mitigate the risk of infusion-related reactions…”
Get full text

Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight by Ielo, Claudia, Fazio, Francesca, Rocchi, Serena, Rizzello, Ilaria, Mancuso, Katia, Zamagni, Elena, Cavo, Michele, Petrucci, Maria Teresa

“…Chimeric antigen receptor (CAR) T-cells have unveiled a promising therapeutic horizon for relapsed/refractory multiple myeloma (R/R MM). Nevertheless, immune…”
Get full text

Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma by Mancuso, Katia, Tacchetti, Paola, Pantani, Lucia, Rocchi, Serena, Rizzello, Ilaria, Caratozzolo, Isola, De Cicco, Gabriella, Fusco, Alessio, Testoni, Nicoletta, Terragna, Carolina, Marzocchi, Giulia, Martello, Marina, Borsi, Enrica, Dozza, Luca, Cavo, Michele, Zamagni, Elena

Get full text

Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents by Tacchetti, Paola, Pezzi, Annalisa, Zamagni, Elena, Pantani, Lucia, Rocchi, Serena, Zannetti, Beatrice Anna, Mancuso, Katia, Rizzello, Ilaria, Cavo, Michele

Get full text

High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients by Borsi, Enrica, Mazzocchetti, Gaia, Dico, Angela Flores, Vigliotta, Ilaria, Martello, Marina, Poletti, Andrea, Solli, Vincenza, Armuzzi, Silvia, Taurisano, Barbara, Kanapari, Ajsi, Pistis, Ignazia, Zamagni, Elena, Tacchetti, Paola, Pantani, Lucia, Mancuso, Katia, Rocchi, Serena, Rizzello, Ilaria, Cavo, Michele, Terragna, Carolina

“…In recent years, the immunoderivative (IMiD) agents have been extensively used for the treatment of multiple myeloma (MM). IMiDs and their newer derivatives…”
Get full text

Treatment optimization for multiple myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in in vitro and ex vivo models by Borsi, Enrica, Martello, Marina, Santacroce, Barbara, Zamagni, Elena, Tacchetti, Paola, Pantani, Lucia, Mancuso, Katia, Rocchi, Serena, Cavo, Michele, Terragna, Carolina

Get full text

Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma by Mancuso, Katia, Zamagni, Elena, Solli, Vincenza, Gabrielli, Liliana, Leone, Marta, Pantani, Lucia, Rocchi, Serena, Rizzello, Ilaria, Tacchetti, Paola, Ghibellini, Stefano, Favero, Emanuele, Ursi, Margherita, Talarico, Marco, Barbato, Simona, Kanapari, Ajsi, Bigi, Flavia, Puppi, Michele, Terragna, Carolina, Borsi, Enrica, Martello, Marina, Poletti, Andrea, Scatà, Alessandra, Nepoti, Giuliana, Ruffini, Barbara, Lazzarotto, Tiziana, Cavo, Michele

“…Long-term kinetics of antibody (Ab) and cell-mediated immune (CMI) response to full anti-SARS-CoV-2 vaccine schedule and booster doses in Multiple Myeloma (MM)…”
Get full text

A New Risk Stratification Model (R2-ISS) in Newly Diagnosed Multiple Myeloma: Analysis of Mature Data from 7077 Patients Collected By European Myeloma Network within Harmony Big Data Platform by D'Agostino, Mattia, Lahuerta, Juan-José, Wester, Ruth, Waage, Anders, Bertsch, Uta, Zamagni, Elena, Mateos, Maria-Victoria, Larocca, Alessandra, Dall'Olio, Daniele, van de Donk, Niels W. C.J., Cairns, David, Rocchi, Serena, Salwender, Hans, Blade Creixenti, Joan, van der Holt, Bronno, Gastone, Castellani, Ciccone, Giovannino, Capra, Andrea, Dürig, Jan, Bringhen, Sara, Zweegman, Sonja, Cavo, Michele, Goldschmidt, Hartmut, Cook, Gordon, Hernández-Rivas, Jesus Maria, San-Miguel, Jesus F., Boccadoro, Mario, Sonneveld, Pieter

“…Background. The Revised International Staging system (R-ISS) is the standard risk stratification model used for newly diagnosed (ND) multiple myeloma (MM)…”
Get full text

The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases by Vigliotta, Ilaria, Armuzzi, Silvia, Barone, Martina, Solli, Vincenza, Pistis, Ignazia, Borsi, Enrica, Taurisano, Barbara, Mazzocchetti, Gaia, Martello, Marina, Poletti, Andrea, Sartor, Chiara, Rizzello, Ilaria, Pantani, Lucia, Tacchetti, Paola, Papayannidis, Cristina, Mancuso, Katia, Rocchi, Serena, Zamagni, Elena, Curti, Antonio, Arpinati, Mario, Cavo, Michele, Terragna, Carolina

“…Introduction Minimal residual disease (MRD) is commonly assessed in bone marrow (BM) aspirate. However, sample quality can impair the MRD measurement, leading…”
Get full text

Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma by Bigi, Flavia, Tacchetti, Paola, Giorgi, Alessandro, Mazzocchetti, Gaia, Solli, Vincenza, Barbato, Simona, Sinigaglia, Barbara, Campanini, Elena, Favero, Emanuele, Talarico, Marco, Puppi, Michele, Rizzello, Ilaria, Rocchi, Serena, Mancuso, Katia, Pantani, Lucia, Cavo, Michele, Zamagni, Elena

“…The impact of daratumumab on CD34+ hematopoietic stem cell (HSC) mobilization has recently been a matter of concern. To address this issue, we compared CD34+…”
Get full text

Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients by Borsi, Enrica, Vigliotta, Ilaria, Poletti, Andrea, Mazzocchetti, Gaia, Solli, Vincenza, Zazzeroni, Luca, Martello, Marina, Armuzzi, Silvia, Taurisano, Barbara, Kanapari, Ajsi, Pistis, Ignazia, Zamagni, Elena, Pantani, Lucia, Rocchi, Serena, Mancuso, Katia, Tacchetti, Paola, Rizzello, Ilaria, Rizzi, Simonetta, Dan, Elisa, Sinigaglia, Barbara, Cavo, Michele, Terragna, Carolina

“…Clonal hematopoiesis of indeterminate potential (CHIP) refers to the phenomenon where a hematopoietic stem cell acquires fitness-increasing mutation(s),…”
Get full text

Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma by Brioli, Annamaria, Zannetti, Beatrice Anna, Zamagni, Elena, Tacchetti, Paola, Pantani, Lucia, Mancuso, Katia, Pezzi, Annalisa, Rocchi, Serena, Cavo, Michele

Get full text